HOME >> BIOLOGY >> NEWS
American Cancer Society funds Space Station scientist who studies how good cells turn bad

Every second, your body's cells get instructions on what they are supposed to do from DNA -- the double-helix strand of deoxyribonucleic acid that is the genetic ingredient essential for life.

In healthy cells, proteins manufacture DNA and remove or repair any broken strands. When proteins fail to repair damaged DNA, good cells may turn bad, resulting in a plethora of diseases, including cancer.

Yearly mammograms and daily inspections for lumps make women intimately aware that bad cells form tumors. According to the America Cancer Society, in 2001 almost 200,000 women were diagnosed with new cases of breast cancer -- and some 40,000 women were killed by the disease.

To understand how these basic molecular processes cause breast cancer, the American Cancer Society has awarded a $768,000, four-year grant to Dr. Gloria Borgstahl, a biochemist at the University of Toledo in Ohio. Borgstahl's grant proposal to the American Cancer Society was rated first of 57 submissions to the Genetic Mechanisms in Cancer grant selection committee.

"I am not discovering a cure for cancer," cautioned Borgstahl, "but the American Cancer Society and NASA recognize that understanding basic molecular processes in the body will ultimately provide the knowledge researchers need to get closer to that cure."

Right now, Borgstahl is doing related experiments on the International Space Station. She is in her first year of research funded by a three-year, $830,000-grant awarded by NASA's Office of Biological and Physical Research as part of the Macromolecular Biotechnology Program at NASA's Marshall Space Flight Center in Huntsville, Ala.

On April 19, the Space Shuttle Atlantis returned with the first biological crystals that she grew on the Space Station.

The American Cancer Society funding will help Borgstahl study Replication Protein A, know as RPA, and another protein called Rad52. Scientists discovered RPA and learned
'"/>

Contact: Steve Roy
steve.roy@msfc.nasa.gov
256-544-0034
NASA/Marshall Space Flight Center News Center
2-May-2002


Page: 1 2 3 4

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/14/2018)... ... December 14, 2018 , ... uBiome, the leader in ... for Microbiome-Derived Diagnostics and Therapeutics” by the US Patent and Trademark Office on ... is an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. ...
(Date:12/13/2018)... ... 2018 , ... Illumina, Kaiser Permanente, ResMed and Aetna were just a few ... and cooking events company has hosted an impressive guest list of Fortune 500 businesses, ... Each group who visits receives a completely customized experience, right down to the menu ...
(Date:12/10/2018)... , ... December 10, 2018 , ... ... strategic alliance to advance their shared goal of accelerating the development of the ... scale-up bioprocess systems to TRT’s core technology around human umbilical cord perivascular cells ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... January 08, 2019 , ... ... announced today that SAGICO will be represented at the 37th Annual J.P. ... Healthcare Conference is the largest and most informative healthcare investment symposium in ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix ... morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today ... drug candidate, code-named "KM-819." KM-819 is an orally active small molecule that ... South Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the ... World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following ... World Economic Forum Annual Meeting brings together leaders of global society–the heads and ...
Breaking Biology Technology:
Cached News: